Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Godaddy Inc (GDDY) vs Medpace Holdings Inc (MEDP) Price & Performance

Godaddy IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Godaddy Inc vs Medpace Holdings Inc — how do they compare? Godaddy Inc trades at $92.26 (market cap $12.09B), while Medpace Holdings Inc trades at $534.43 (market cap $15.11B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Godaddy Inc nearer its low. Which is the better fit depends on your goals.

GDDYMEDP
Market Cap
$12.09B$15.11B
Sector
TechnologyTechnology
52-Week High
$169.40$620.59
52-Week Low
$75.07$308.88
Enterprise Value
$14.67B$14.58B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Godaddy Inc

GoDaddy (GDDY) trades at $91.10, showing modest daily gains. The stock presents a mixed picture: strong technical indicators signal a bullish trend, while fundamentals reveal robust profitability and consistent earnings beats. However, a high P/B ratio and ongoing securities litigation investigations introduce notable risks. The company continues to innovate, recently launching an AI-powered developer platform to expand its service ecosystem.

The outlook is cautiously optimistic. A significant analyst consensus price target of $123 suggests substantial upside potential, supported by strong cash flow and share buybacks. Primary risks include the high valuation on book value, legal overhang from shareholder investigations, and potential revenue growth deceleration. The stock's investment case hinges on execution of its AI initiatives and maintaining its margin profile.

Medpace Holdings Inc

Medpace (MEDP) trades at $534.85, down 0.25% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company shows strong profitability with a 17.19% net income margin and 77.25% ROE, though valuations are elevated with a P/E of 33.31. Recent earnings have consistently beaten estimates, and cash flow is projected to improve in 2026. News highlights focus on CRO demand shifts and a class action lawsuit from June 2026.

Outlook remains mixed; strong earnings momentum and operational efficiency support upside, but high valuation and legal overhangs pose risks. Analyst consensus is cautious with a $497 price target below current levels, suggesting limited near-term appreciation potential amid balanced investor sentiment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Godaddy Inc

GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.

Read more on GDDY

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP